Figure 2. Correlation of Pygo2 expression with patient survival rate.
(A) Kaplan-Meier survival curves obtained using 209 human brain glioma patients and 9 normal subjects. (B–E) Kaplan-Meier survival curves of Pygo2 over-expression were classified into phases I (B, n = 26), II (C, n = 77), III (D, n = 59) and IV (E, n = 47) based on the WHO guideline.